Innovative Licensing and Access Pathway
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access. Read more
News from Medicines and Healthcare products Regulatory Agency, published 30 March 2021, last updated 23 August 2021.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (24 septembre 2021). Innovative Licensing and Access Pathway. ELSIBI. Consulté le 13 janvier 2026 à l’adresse https://doi.org/10.58079/o5st





